id | C00001714 |
---|---|
Name | Eburnamonine |
CAS RN | 4880-88-0 |
Standard InChI | InChI=1S/C19H22N2O/c1-2-19-9-5-10-20-11-8-14-13-6-3-4-7-15(13)21(16(22)12-19)17(14)18(19)20/h3-4,6-7,18H,2,5,8-12H2,1H3/t18-,19+/m1/s1 |
Standard InChI (Main Layer) | InChI=1S/C19H22N2O/c1-2-19-9-5-10-20-11-8-14-13-6-3-4-7-15(13)21(16(22)12-19)17(14)18(19)20/h3-4,6-7,18H,2,5,8-12H2,1H3 |
Phytochemical cluster | No. 4 |
---|---|
KCF-S cluster | No. 502 |
By standard InChI | CHEMBL1892145 |
---|---|
By standard InChI Main Layer | CHEMBL1318553 CHEMBL1553441 CHEMBL1733074 CHEMBL1892145 |
By LinkDB | C09149 |
---|
By CAS RN |
---|
class name | count |
---|---|
asterids | 2 |
family name | count |
---|---|
Apocynaceae | 2 |
KNApSAcK organism | *ID | *family | *plant class | *kingdom |
---|---|---|---|---|
Hunteria eburnea Pichon. | 141570 | Apocynaceae | asterids | Viridiplantae |
Vinca minor | 60093 | Apocynaceae | asterids | Viridiplantae |
accession | description | class description | compound | assay ID (# of activities) |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|---|
P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | CHEMBL1318553 |
CHEMBL1614110
(3)
CHEMBL1741321
(2)
|
1 / 0 |
Q99700 | Ataxin-2 | Unclassified protein | CHEMBL1892145 |
CHEMBL2114784
(1)
|
1 / 1 |
P02545 | Prelamin-A/C | Unclassified protein | CHEMBL1318553 |
CHEMBL1614544
(1)
|
11 / 10 |
P16473 | Thyrotropin receptor | Glycohormone receptor | CHEMBL1318553 |
CHEMBL1614281
(1)
CHEMBL1614361
(1)
|
3 / 2 |
P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | CHEMBL1318553 |
CHEMBL1614027
(1)
CHEMBL1741325
(2)
|
0 / 1 |
P84022 | Mothers against decapentaplegic homolog 3 | Unclassified protein | CHEMBL1733074 |
CHEMBL1794584
(1)
|
2 / 0 |
O75496 | Geminin | Unclassified protein | CHEMBL1318553 CHEMBL1892145 |
CHEMBL2114843
(2)
CHEMBL2114780
(2)
|
0 / 0 |
P43220 | Glucagon-like peptide 1 receptor | Glucagon-like peptide receptor | CHEMBL1733074 CHEMBL1892145 |
CHEMBL2114788
(2)
|
0 / 0 |
Q9HC16 | DNA dC->dU-editing enzyme APOBEC-3G | Enzyme | CHEMBL1733074 CHEMBL1892145 |
CHEMBL1963863
(2)
|
0 / 0 |
P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | CHEMBL1318553 |
CHEMBL1741322
(2)
|
0 / 0 |
P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | CHEMBL1318553 |
CHEMBL1613777
(2)
CHEMBL1741323
(2)
|
1 / 1 |
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | CHEMBL1318553 CHEMBL1553441 |
CHEMBL1614108
(3)
CHEMBL1613886
(3)
CHEMBL1741324 (2) |
0 / 1 |
Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | CHEMBL1733074 |
CHEMBL1738442
(1)
|
0 / 0 |
O75874 | Isocitrate dehydrogenase [NADP] cytoplasmic | Enzyme | CHEMBL1892145 |
CHEMBL2354311
(1)
|
1 / 0 |
OMIM | preferred title | UniProt |
---|---|---|
#115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
#212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
#605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
#114500 | Colorectal cancer; crc |
P84022
|
#609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
#608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
#181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
#137800 | Glioma susceptibility 1; glm1 |
O75874
|
#610140 | Heart-hand syndrome, slovenian type |
P02545
|
#176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
#603373 | Hyperthyroidism, familial gestational |
P16473
|
#609152 | Hyperthyroidism, nonautoimmune |
P16473
|
#275200 | Hypothyroidism, congenital, nongoitrous, 1; chng1 |
P16473
|
#151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
#613795 | Loeys-dietz syndrome, type 3; lds3 |
P84022
|
#248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
#613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
#159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
#275210 | Restrictive dermopathy, lethal |
P02545
|
#183090 | Spinocerebellar ataxia 2; sca2 |
Q99700
|
KEGG | disease name | UniProt |
---|---|---|
H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
|
H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
|
H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
H00663 | Restrictive dermopathy |
P02545
(related)
|
H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
H00036 | Osteosarcoma |
P08684
(marker)
|
H01205 | Coumarin resistance |
P11712
(related)
|
H00250 | Congenital nongoitrous hypothyroidism (CHNG) |
P16473
(related)
|
H01269 | Congenital hyperthyroidism |
P16473
(related)
|
H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
H00063 | Spinocerebellar ataxia (SCA) |
Q99700
(related)
|